A licensed provider reviews medical history, medications, recovery context, and safety considerations to understand stability and determine appropriate next steps.
No. cope now provides clinical evaluation and prescription-based care planning, not substance use counseling or behavioral therapy.
Prescription decisions are not automatic. Discussion does not imply prescription, and not all evaluations result in treatment.
That caution is appropriate. Recovery evaluations prioritize safety, stability, and careful decision-making over rapid changes.
In some cases, clinicians may discuss non-intoxicating, pharmacist-compounded cannabinoid formulations as one category of adjunctive option, when appropriate.
Yes. All evaluations take place through secure telemedicine, designed to protect privacy and support thoughtful, safety-focused clinical conversations.

